Ionolyte

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride and Sodium Acetate Trihydrate, the active ingredients in Ionolyte, are an electrolyte solution presented as an injectable solution for intravenous use. It is used to correct electrolyte depletion and support fluid balance in patients undergoing surgery, critical care, or experiencing electrolyte loss.

GNH USA supplies Ionolyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ionolyte is an intravenous electrolyte solution used to manage disorders of fluid and electrolyte balance.

Electrolyte depletion: restores magnesium, potassium, sodium and acetate concentrations to physiologic levels. Fluid replacement therapy: provides isotonic fluid volume to maintain intravascular volume. Peri‑operative care: maintains electrolyte homeostasis during surgery or critical‑care interventions.

Ionolyte may be associated with infusion‑related reactions and electrolyte‑related abnormalities.

Common Side Effects: - Mild infusion site irritation or erythema. - Transient hypermagnesemia causing mild hypotension. - Slight increase in serum potassium leading to mild nausea. - Temporary rise in serum sodium with mild thirst. - Mild metabolic alkalosis from acetate metabolism.

Serious or Rare Side Effects: - Severe hypermagnesemia with respiratory depression. - Life‑threatening hyperkalemia causing cardiac arrhythmia. - Hypernatremia leading to neurologic symptoms. - Acute acetate toxicity resulting in metabolic acidosis. - Anaphylactic reaction to solution components.

Ionolyte should be administered with careful clinical monitoring.

Assess baseline electrolytes: obtain serum magnesium, potassium, sodium and acid‑base status before infusion. Renal impairment: adjust infusion rate and monitor electrolytes closely. Cardiac disease: watch for arrhythmias when correcting potassium or magnesium. Fluid overload risk: limit total volume in patients with heart failure. Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ionolyte may interact with drugs that affect electrolyte balance or cardiac conduction.

Major Interactions (Avoid): - Concurrent high‑dose potassium supplements: risk of severe hyperkalemia. - Magnesium‑containing laxatives or antacids: may cause excessive magnesium levels. - Sodium‑rich IV fluids: can precipitate hypernatremia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may potentiate potassium elevation. - Digoxin: altered potassium may affect drug toxicity. - Loop diuretics: increased electrolyte loss may require dose adjustment of Ionolyte.